云南中医学院学报
雲南中醫學院學報
운남중의학원학보
JOURNAL OF YUNNAN COLLEGE OF TRADITIONAL CHINESE MEDICINE
2015年
3期
38-42
,共5页
腹泻型%肠易激综合征%穴位注射%黄芪注射液%曲美布汀%临床疗效
腹瀉型%腸易激綜閤徵%穴位註射%黃芪註射液%麯美佈汀%臨床療效
복사형%장역격종합정%혈위주사%황기주사액%곡미포정%림상료효
diarrhea- predominant%irritable bowel syndrome%acupuncture point injection%Astragalus injection%Trimebutine%clinical efficacy
目的:观察黄芪注射液穴位注射配合西药曲美布汀治疗腹泻型肠易激综合征的临床疗效。方法将96例腹泻型肠易激综合征患者随机分为治疗组和对照组,其中治疗组47例,对照组49例。2组患者均口服曲美布汀,每次1片,3次/d,共服用2周,治疗组在此基础上采用黄芪注射液穴位注射,选穴:心俞、肝俞、脾俞,隔日1次,共治疗7次。2组患者采用IBS-SSS量表对患者治疗结束时、治疗结束后1个月和3个月临床症状改善情况进行评价。结果治疗结束时2组患者IBS-SSS评分均较治疗前有显著改善,差异具有统计学意义(P<0.05),在治疗结束时和治疗后1个月,2组组间比较差异有统计学意义(P<0.05),治疗组优于对照组,但治疗后3个月,2组差异无统计学意义(P>0.05)。在临床症状改善方面,治疗组在腹痛程度和腹痛频率方面改善明显优于对照组,差异有统计学意义(P<0.05)。结论黄芪注射液穴位注射配合曲美布汀治疗腹泻型肠易激综合征有良好的临床疗效,可以明显改善患者腹痛或腹胀等主要症状。
目的:觀察黃芪註射液穴位註射配閤西藥麯美佈汀治療腹瀉型腸易激綜閤徵的臨床療效。方法將96例腹瀉型腸易激綜閤徵患者隨機分為治療組和對照組,其中治療組47例,對照組49例。2組患者均口服麯美佈汀,每次1片,3次/d,共服用2週,治療組在此基礎上採用黃芪註射液穴位註射,選穴:心俞、肝俞、脾俞,隔日1次,共治療7次。2組患者採用IBS-SSS量錶對患者治療結束時、治療結束後1箇月和3箇月臨床癥狀改善情況進行評價。結果治療結束時2組患者IBS-SSS評分均較治療前有顯著改善,差異具有統計學意義(P<0.05),在治療結束時和治療後1箇月,2組組間比較差異有統計學意義(P<0.05),治療組優于對照組,但治療後3箇月,2組差異無統計學意義(P>0.05)。在臨床癥狀改善方麵,治療組在腹痛程度和腹痛頻率方麵改善明顯優于對照組,差異有統計學意義(P<0.05)。結論黃芪註射液穴位註射配閤麯美佈汀治療腹瀉型腸易激綜閤徵有良好的臨床療效,可以明顯改善患者腹痛或腹脹等主要癥狀。
목적:관찰황기주사액혈위주사배합서약곡미포정치료복사형장역격종합정적림상료효。방법장96례복사형장역격종합정환자수궤분위치료조화대조조,기중치료조47례,대조조49례。2조환자균구복곡미포정,매차1편,3차/d,공복용2주,치료조재차기출상채용황기주사액혈위주사,선혈:심유、간유、비유,격일1차,공치료7차。2조환자채용IBS-SSS량표대환자치료결속시、치료결속후1개월화3개월림상증상개선정황진행평개。결과치료결속시2조환자IBS-SSS평분균교치료전유현저개선,차이구유통계학의의(P<0.05),재치료결속시화치료후1개월,2조조간비교차이유통계학의의(P<0.05),치료조우우대조조,단치료후3개월,2조차이무통계학의의(P>0.05)。재림상증상개선방면,치료조재복통정도화복통빈솔방면개선명현우우대조조,차이유통계학의의(P<0.05)。결론황기주사액혈위주사배합곡미포정치료복사형장역격종합정유량호적림상료효,가이명현개선환자복통혹복창등주요증상。
Objective To investigate the effect of acupuncture point injection astragalus injection combined with trimebutine on diarrhea-predominant irritable bowel syndrome(IBS-D). Methods Using the randomized controlled method,ninety-six IBS-D were divided into a treatment group(47 cases)and control group(49 cases). Both groups received trimebutine,one tablet each time, three times a day,taking two weeks,the treatment group received point Xinshu,Ganshu,Pishu injection of astragalus in addition,a total of seven times in treatment. After two weeks,using the IBS-SSS scale for patients at the end of the treatment,one month and three months to evaluate clinical synmptoms improve the situation. Results IBS-SSS score was improved significantly after treatment in the two groups(P<0.05),and the improvements in the treatment group were superior to those in control group after treatment and 1 month(P<0.05),however,3 month after treatment in the two groups there was no statiscally significant difference(P>0.05). In terms of clinical symptoms improved,the treatment group improved in terms of frequency of abdominal pain and abdominal pain was better than control group,the difference was statistically significant(P<0.05). Conclusion The method of acupuncture point injection astragalus injection combined with trimebutine can alleviate the symptoms of IBS-D and it is effective.